©The Author(s) 2015.
World J Gastrointest Oncol. Sep 15, 2015; 7(9): 161-171
Published online Sep 15, 2015. doi: 10.4251/wjgo.v7.i9.161
Published online Sep 15, 2015. doi: 10.4251/wjgo.v7.i9.161
Table 11 Hepatocellular carcinoma screening depending on medical specialty
| Specialty | P value | ||||
| Specialty A1 | Specialty B2 | ||||
| n | % | n | % | ||
| HCC surveillance | 0.193 | ||||
| Yes | 32 | 25 | 3 | 13 | |
| No | 98 | 75 | 21 | 87 | |
| Screening of patients with HCV cirrhosis and SVR | 0.79 | ||||
| Yes | 109 | 84 | 19 | 79 | |
| No | 21 | 16 | 5 | 21 | |
| Screening of patients with hemochromatosis | 0.030a | ||||
| Yes | 94 | 72.3 | 12 | 50 | |
| No | 36 | 27.7 | 12 | 50 | |
| No. of incidental HCCs/month | 0.418 | ||||
| 0 | 33 | 25 | 8 | 33 | |
| 1 or more | 97 | 75 | 16 | 67 | |
| No. of HCCs/month | 0.759 | ||||
| 0 | 34 | 26 | 7 | 29 | |
| 1 or more | 96 | 74 | 17 | 71 | |
- Citation: Hassany SM, Moustafa EFA, Taher ME, Abdeltwab AA, Blum HE. Screening for hepatocellular carcinoma by Egyptian physicians. World J Gastrointest Oncol 2015; 7(9): 161-171
- URL: https://www.wjgnet.com/1948-5204/full/v7/i9/161.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v7.i9.161